Recipient dendritic cells, but not B cells, are required antigen-presenting cells for peripheral alloreactive CD8+ T-cell tolerance.
Induction of mixed allogeneic chimerism is a promising approach for achieving donor-specific tolerance, thereby obviating the need for life-long immunosuppression for solid organ allograft acceptance. In mice receiving a low dose (3Gy) of total body irradiation, allogeneic bone marrow transplantation combined with anti-CD154 tolerizes peripheral CD4 and CD8 T cells, allowing achievement of mixed chimerism with specific tolerance to donor. With this approach, peripheral CD8 T-cell tolerance requires recipient MHC class II, CD4 T cells, B cells and DCs. Recipient-type B cells from chimeras that were tolerant to donor still promoted CD8 T-cell tolerance, but their role could not be replaced by donor-type B cells. Using recipients whose B cells or DCs specifically lack MHC class I and/or class II or lack CD80 and CD86, we demonstrate that dendritic cells (DCs) must express CD80/86 and either MHC class I or class II to promote CD8 tolerance. In contrast, B cells, though required, did not need to express MHC class I or class II or CD80/86 to promote CD8 tolerance. Moreover, recipient IDO and IL-10 were not required. Thus, antigen presentation by recipient DCs and not by B cells is critical for peripheral alloreactive CD8 T cell tolerance.
Mollov
J L
JL
Transplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
Lucas
C L
CL
Transplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
Haspot
F
F
Transplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
Gaspar
J Kurtz C
JKC
Transplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
Guzman
A
A
Transplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
Sykes
M
M
Transplantation Biology Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
D000818:Animals; D000938:Antigen-Presenting Cells / Q000166:cytology / Q000276:immunology*; D001402:B-Lymphocytes / Q000166:cytology / Q000276:immunology*; D018122:B7-1 Antigen / Q000096:biosynthesis; D051940:B7-2 Antigen / Q000096:biosynthesis; D023201:CD40 Ligand / Q000096:biosynthesis; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology*; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology*; D005260:Female; D006649:Histocompatibility Antigens / Q000378:metabolism; D007108:Immune Tolerance / Q000276:immunology*; D016753:Interleukin-10 / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D019172:Transplantation Conditioning
D018122:B7-1 Antigen; D051940:B7-2 Antigen; D006649:Histocompatibility Antigens; D016753:Interleukin-10; D023201:CD40 Ligand